| Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases G Cavalli, S Colafrancesco, G Emmi, M Imazio, G Lopalco, MC Maggio, ... Autoimmunity reviews 20 (3), 102763, 2021 | 188 | 2021 |
| Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study C Fabiani, A Vitale, G Emmi, G Lopalco, L Vannozzi, S Guerriero, ... Clinical rheumatology 36, 191-197, 2017 | 136 | 2017 |
| Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives G Lopalco, L Cantarini, A Vitale, F Iannone, MG Anelli, L Andreozzi, ... Mediators of inflammation 2015, 2015 | 120 | 2015 |
| Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: the IRAP (International Registry of Anakinra for Pericarditis) study M Imazio, A Andreis, GM De Ferrari, PC Cremer, V Mardigyan, ... European journal of preventive cardiology 27 (9), 956-964, 2020 | 119 | 2020 |
| Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study G Emmi, R Talarico, G Lopalco, R Cimaz, F Cantini, O Viapiana, I Olivieri, ... Clinical Rheumatology 35, 1281-1286, 2016 | 114 | 2016 |
| Efficacy and safety of adalimumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study C Fabiani, A Vitale, G Emmi, L Vannozzi, G Lopalco, S Guerriero, ... Clinical rheumatology 36, 183-189, 2017 | 108 | 2017 |
| Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection M Barone, A Notarnicola, G Lopalco, MT Viggiani, F Sebastiani, M Covelli, ... Hepatology 62 (1), 40-46, 2015 | 106 | 2015 |
| Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease L Cantarini, G Lopalco, F Caso, L Costa, F Iannone, G Lapadula, ... Autoimmunity Reviews 14 (1), 1-9, 2015 | 104 | 2015 |
| Sarcopenia in patients with rheumatic diseases: prevalence and associated risk factors M Barone, MT Viggiani, MG Anelli, R Fanizzi, O Lorusso, G Lopalco, ... Journal of clinical medicine 7 (12), 504, 2018 | 96 | 2018 |
| Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset Still’s disease: a multicentre retrospective observational study S Colafrancesco, R Priori, G Valesini, L Argolini, E Baldissera, E Bartoloni, ... Frontiers in pharmacology 8, 369, 2017 | 96 | 2017 |
| Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study A Bettiol, ML Urban, L Dagna, V Cottin, F Franceschini, S Del Giacco, ... Arthritis & Rheumatology 74 (2), 295-306, 2022 | 93 | 2022 |
| A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center … A Vitale, A Insalaco, P Sfriso, G Lopalco, G Emmi, M Cattalini, R Manna, ... Frontiers in pharmacology 7, 380, 2016 | 88 | 2016 |
| Relapsing polychondritis: an update on pathogenesis, clinical features, diagnostic tools, and therapeutic perspectives A Vitale, J Sota, D Rigante, G Lopalco, F Molinaro, M Messina, F Iannone, ... Current rheumatology reports 18, 1-12, 2016 | 88 | 2016 |
| A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome D Rigante, A Vitale, MF Natale, G Lopalco, L Andreozzi, B Frediani, ... Clinical rheumatology 36, 463-468, 2017 | 81 | 2017 |
| Key facts and hot spots on tumor necrosis factor receptor‐associated periodic syndrome D Rigante, G Lopalco, A Vitale, OM Lucherini, C De Clemente, F Caso, ... Clinical Rheumatology 33, 1197-1207, 2014 | 75 | 2014 |
| Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis L Cantarini, G Lopalco, C Selmi, S Napodano, G De Rosa, F Caso, ... Autoimmunity reviews 14 (2), 90-97, 2015 | 74 | 2015 |
| Unveiling the efficacy, safety, and tolerability of anti-interleukin-1 treatment in monogenic and multifactorial autoinflammatory diseases A Bettiol, G Lopalco, G Emmi, L Cantarini, ML Urban, A Vitale, N Denora, ... International journal of molecular sciences 20 (8), 1898, 2019 | 71 | 2019 |
| Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study J Sota, A Vitale, A Insalaco, P Sfriso, G Lopalco, G Emmi, M Cattalini, ... Clinical Rheumatology 37, 2233-2240, 2018 | 70 | 2018 |
| Cytokine signatures in mucocutaneous and ocular behcet’s disease G Lopalco, OM Lucherini, A Lopalco, V Venerito, C Fabiani, B Frediani, ... Frontiers in Immunology 8, 200, 2017 | 67 | 2017 |
| Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational … C Fabiani, A Vitale, D Rigante, G Emmi, A Bitossi, G Lopalco, J Sota, ... Clinical rheumatology 38, 407-415, 2019 | 65 | 2019 |
Galeazzi MauroProfessore Ordinario di Reumatologia, Università di SienaVerified email at unisi.it
